Sen. Angus S. King Jr. Buys Eli Lilly Shares

Independent senator from Maine discloses purchase of $1,001 to $15,000 in Eli Lilly stock

Jan. 31, 2026 at 10:31pm

Got story updates? Submit your updates here. ›

Senator Angus S. King Jr., an independent from Maine, recently bought between $1,001 and $15,000 worth of shares in pharmaceutical company Eli Lilly and Company. The purchase was disclosed in a filing on January 26th and was made on December 29th.

Why it matters

As a U.S. Senator, King's stock trades are closely watched for potential conflicts of interest or insider trading. Eli Lilly is a major pharmaceutical company that could be impacted by legislation or government policies, making King's investment noteworthy.

The details

According to the filing, King bought the Eli Lilly shares on December 29th. Eli Lilly's stock price has been on the rise, trading between $623.78 and $1,133.95 over the past 52 weeks. The company recently increased its quarterly dividend and has a market capitalization of over $981 billion.

  • Senator King disclosed the Eli Lilly stock purchase on January 26, 2026.
  • The stock purchase was made on December 29, 2025.

The players

Angus S. King Jr.

An independent U.S. Senator from Maine who was re-elected in 2024 and is currently serving a term that ends on January 3, 2031.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. Eli Lilly researches, develops, manufactures and commercializes a broad range of medicines and therapies worldwide.

Got photos? Submit your photos here. ›

The takeaway

As a U.S. Senator, Angus King's stock trades are closely monitored for potential conflicts of interest. His investment in Eli Lilly, a major pharmaceutical firm, highlights the need for ongoing transparency and oversight around elected officials' financial holdings.